Clal Biotechnology (Israel) Price Prediction and Hype Density Breakdown

CBI -- Israel Stock  

ILS 287.70  8.50  3.04%

We analyze noise-free headlines and recent hype associated with Clal Biotechnology Industries Ltd which may create opportunities for some arbitrage if properly timed. With Clal Biotechnology hype-based prediction module you can estimate the value of Clal Biotechnology Industries Ltd from the prospective of Clal Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Clal Biotechnology over a specific investment horizon. Check also Trending Equities.
Horizon     30 Days    Login   to change

Clal Biotechnology After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Clal Biotechnology Estimiated After-Hype Price Volatility

March 18, 2019
Current Value
After-hype Price
Target Odds
Odds Odds
Clal Biotechnology is Unknown risk asset. Analysis and calculation of next after-hype price of Clal Biotechnology is based on 2 months time horizon.

Clal Biotechnology Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.16% 3.05% 1.31%  1.16% 4 Events / Month6 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Clal Biotechnology Hype Timeline

Clal Biotechnology is currently traded for 287.70on Tel Aviv Stock Exchange of Israel. The entity has historical hype elasticity of -1.31 and average elasticity to hype of competition of -1.16. Clal Biotechnology Industries Ltd is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 37.2%. The immediate return on the next news is anticipated to be very small where as daily expected return is currently at 0.16%. The volatility of relative hype elasticity to Clal Biotechnology is about 42.19%%. The volatility of related hype on Clal Biotechnology is about 42.19% with expected price after next announcement by competition of 286.54. The company recorded loss per share of 0.44. Clal Biotechnology had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be in about 4 days.
Check also Trending Equities.

Clal Biotechnology Related Hype Analysis

At Risk
Kamada Ltd(3.00) 5 per month 0.58  0.16  4.33 (1.86)  8.57 
BioTime(37.30) 7 per month 5.86  0.0218  16.89 (9.54)  31.55 
Compugen Ltd(42.00) 5 per month 4.76  0.0224  9.25 (7.66)  19.73 
Clal Biotechnology Industries Ltd(8.20) 4 per month 0.00 (0.09)  6.30 (6.15)  14.16 
Pluristem Therapeutics 7.20 5 per month 4.80 (0.0223)  5.81 (9.18)  40.23 
Protalix BioTherapeutics(1.00) 5 per month 4.35  0.0334  13.64 (8.40)  27.91 
BioLine Rx Ltd 2.00 6 per month 0.00 (0.20)  7.15 (8.35)  31.03 
Can Fite BioPharma Ltd 10.00 5 per month 0.00 (0.14)  4.10 (5.50)  23.05 
BioLight Life Sciences Ltd 0.00 0 per month 0.00 (0.05)  6.20 (6.99)  14.41 
Hadasit Bio Holdings Ltd 0.00 0 per month 0.00 (0.10)  3.58 (4.83)  13.43 

Investors are also interested in

Purchased over 40 shares
Active 2 days ago
Purchased few shares
Active 2 days ago
Purchased over 300 shares
Active 2 days ago
Purchased over 300 shares
Active 2 days ago
Check also Trending Equities. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.